139 related articles for article (PubMed ID: 17613856)
21. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
Mhawech P; Uchida T; Pelte MF
Hum Pathol; 2002 Nov; 33(11):1136-40. PubMed ID: 12454820
[TBL] [Abstract][Full Text] [Related]
22. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
23. Thyroid transcription factor-1 staining is useful in identifying brain metastases of pulmonary origin.
Prok AL; Prayson RA
Ann Diagn Pathol; 2006 Apr; 10(2):67-71. PubMed ID: 16546039
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer.
Parwani AV; Marlow C; Demarzo AM; Mikolajczyk SD; Rittenhouse HG; Veltri RW; Chan TY
Am J Surg Pathol; 2006 Oct; 30(10):1231-6. PubMed ID: 17001152
[TBL] [Abstract][Full Text] [Related]
25. Toward an evidence-based proposal for the best minimal immunohistochemical panel to infer lung carcinoma in metastatic supraclavicular lymph node.
Kumar R; Jambhekar NA; Marchevsky AM; Pramesh CS; Karimundackal G; Agarwal JP; Dikshit R
Ann Diagn Pathol; 2014 Apr; 18(2):53-7. PubMed ID: 24360802
[TBL] [Abstract][Full Text] [Related]
26. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
28. Metastatic thoracic lymph node carcinoma of unknown origin on which we performed two kinds of immunohistochemical examinations.
Yoshino N; Yamauchi S; Hino M; Ohaki Y; Koizumi K; Shimizu K
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):283-6. PubMed ID: 16977301
[TBL] [Abstract][Full Text] [Related]
29. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
Karabork A; Kaygusuz G; Ekinci C
Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
31. Sinonasal adenocarcinoma: immunohistochemical marking and expression of oncoproteins.
Bashir AA; Robinson RA; Benda JA; Smith RB
Head Neck; 2003 Sep; 25(9):763-71. PubMed ID: 12953313
[TBL] [Abstract][Full Text] [Related]
32. Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases.
Sung MT; Maclennan GT; Lopez-Beltran A; Zhang S; Montironi R; Cheng L
Am J Surg Pathol; 2008 Jan; 32(1):146-55. PubMed ID: 18162782
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
[TBL] [Abstract][Full Text] [Related]
34. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
35. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
Pires Y; Andrade L; Cuello M; Chuaqui R
Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal.
Saeed S; Keehn CA; Morgan MB
J Cutan Pathol; 2004 Jul; 31(6):419-30. PubMed ID: 15186430
[TBL] [Abstract][Full Text] [Related]
38. Parachordoma is not distinguishable from axial chordoma using immunohistochemistry.
Scolyer RA; Bonar SF; Palmer AA; Barr EM; Wills EJ; Stalley P; Schatz J; Soper J; Li LX; McCarthy SW
Pathol Int; 2004 May; 54(5):364-70. PubMed ID: 15086843
[TBL] [Abstract][Full Text] [Related]
39. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Fucich LF; Cheles MK; Thung SN; Gerber MA; Marrogi AJ
Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center.
Sariya D; Ruth K; Adams-McDonnell R; Cusack C; Xu X; Elenitsas R; Seykora J; Pasha T; Zhang P; Baldassano M; Lessin SR; Wu H
Arch Dermatol; 2007 May; 143(5):613-20. PubMed ID: 17515511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
